CORE group

18/08/2025

23/07/2025

CORE Group
Collaborative Oncology Research & Education Group
SPEAKERS

Himalaya 5 Years Update
BY:
Dr. Shokry El-Azab
Assistant Professor of Clinical Oncology – MUH
Time to Reach Beyond in Biliary Tract Cancer
BY:
Dr. Ahmed Eltantawy
Assistant Professor and Consultant of Oncology and Hematology

Dr. Mohamed Farouk
Moderator

🗓 Tuesday – July 29, 2025
🕘 9:00 PM
📍 Al Sabbahi Restaurant – Kanat Al Sweis Street

Sponsored by:
CORE Group & AstraZeneca

Let me know if you want a more formal or design-ready version!

https://www.facebook.com/share/p/16XwShx62f/

https://www.facebook.com/share/p/16XwShx62f/

15/07/2025

Treatment sequencing in HER2+ metastatic breast cancer is complex and is influenced by efficacy and individual patient priorities. As the therapeutic landscape continues to evolve rapidly, staying current with optimal sequencing strategies is essential for maximizing treatment efficacy and maintaining quality of life.

In this Clinical Case Challenge, test your ability to select appropriate treatment options across multiple lines of therapy using key patient-, disease-, and treatment-related factors.

28/02/2023

An exciting interactive session on the systemic traetme t of locally advanced HCC patients.

26/12/2022

Please register here
Don't forget to bring your laptop.

Thursday December 29th 2022

26/12/2022

You are kindly invited to the 1st CORE Contouring workshop sponsored by Eva Pharma. After presenting a brief overview about nodal volume delineation in adjuvant breast radiotherapy a hands on Contouring Session for a case post conservative breast surgery radiotherapy moderated by Dr. Ahmed Ramadan. Dr. Mostafa Elebrashi will present the updated results of Monarch 2 trial for treatment of HR- positive metastatic Breast Cancer.